1,262
Views
2
CrossRef citations to date
0
Altmetric
RESEARCH ARTICLE

Topically applied pH-responsive nanogels for alkyl radical-based therapy against psoriasiform hyperplasia

, , , , , & show all
Article: 2245169 | Received 07 Aug 2022, Accepted 01 Aug 2023, Published online: 10 Aug 2023
 

Abstract

Phototherapy is a conventional antipsoriatic approach based on oxygen-relevant generation of oxidative stress to inhibit keratinocyte hyperproliferation. However, this therapy can be restricted due to local hypoxia in psoriatic lesions. The generation of alkyl radicals is oxygen-independent and suppresses hyperproliferation. Herein, we established alkyl radical-based therapy to treat psoriatic hyperplasia. Because alkyl radicals are short-lived compounds, we loaded 2,2'-azobis[2-(2-imidazolin-2-yl)propane] dihydrochloride (AIPH) as a precursor of alkyl radicals into the chitosan nanogels to improve stability. The present study presented a topically applied nanogel that led to a pH-responsive network sensitive to skin pH. This pH responsiveness of the nanogels allowed fast alkyl radical release in the target site. The physicochemical properties of the prepared nanogels were determined through size, zeta potential, scanning electron microscopy, and absorption spectroscopy. The antipsoriatic activity was examined with keratinocyte- and animal-based studies. The nanogels displayed a smooth and spherical morphology with a hydrodynamic diameter of 215 nm. This size was largely increased as the environmental pH increased to 6. The nanogels heated at 44 °C produced alkyl radicals to induce keratinocyte death through the necrosis pathway. Bioimaging demonstrated that topically applied nanogels could deliver alkyl radicals into the epidermis. This targeting was accompanied by the accumulation of free radicals in the epidermis according to the 2′,7′-dichlorodihydrofluorescein diacetate assay. The imiquimod-stimulated psoriasiform animal model indicated a remarkable reduction in erythema, scaling, and overexpressed cytokines upon topical treatment of the nanogels. The transepidermal water loss of the psoriasiform skin was inhibited from 51.7 to 27.0 g/m2/h, suggesting barrier function recovery by the nanocarriers. The nanogels lowered hyperplasia by decreasing the epidermal thickness from 212 to 89 μm. The incorporation of 8-hydroxypyrene-1,3,6-trisulfonic acid (HPTS) as a pH-sensitive fluorescence dye in the nanogels could be used to diagnose the severity of the psoriasiform plaque due to the stronger fluorescence of HPTS in skin with lower pH (psoriasiform skin pH = 4.4) than in healthy skin (pH = 4.9). It was possible to deliver the prepared nanogels into the epidermis to restrain hyperplasia without causing cutaneous irritation.

GRAPHICAL ABSTRACT

Author contribution

Conceptualization: GRN and JYF; methodology GRN and CCL; software, GRN, ZCL, and AA; formal analysis, GRN, CCL, and SCY; investigation, GRN and EH; writing—original draft preparation, GRN and JYF; writing—review and editing, CCL and EH; supervision, AA and JYF.

Ethical approval statement

The justification for use of animals was that the animals were needed in research to develop novel therapies to treat diseases. We tested in animals to see whether the pH-responsive nanogels were safe and effective for the management of psoriasiform lesion. Mice were housed in a specific pathogen-free facility where cages were changed on a weekly basis. Cages, bedding, food, and acidified water (pH 2.5–3.0) were autoclaved prior to use. Ambient temperature was maintained at 23 °C and 5% Clidox-S was used as the disinfectant. The steps taken to minimize suffering Information on the mode of anesthesia included: careful attention to animal husbandry, the training to the operators, gentle and quiet handling, and limitation of stressors imposed on the animals. This animal study was conducted with approval from the Ethics Committee of Chang Gung University (CGU108-101). This study was conducted in accordance with the declaration of Helsinki. The experimental processes complied with the European Community legislation (Directive 86/609/EEC). All methods were reported in accordance with ARRIVE guidelines.

Disclosure statement

The authors declare no competing interests.

Data availability statement

Data available on request from the authors.

Additional information

Funding

Funding of this work was provided by Ministry of Science and Technology of Taiwan (MOST-110-2330-B-182-011-MY3) and Chang Gung Memorial Hospital (CMRPG3L0931).